Skip to content

Foresight Intracardiac Echocardiography (ICE) System

Visualization of Human Cardiovascular Anatomy With Foresight Intracardiac Echocardiography (ICE) System

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02514876
Enrollment
10
Registered
2015-08-04
Start date
2015-09-30
Completion date
2016-05-05
Last updated
2017-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Brief summary

This study will evaluate the efficacy of 2D forward-looking and 3D Intracardiac Echocardiography (ICE) to guide septal punctures during Atrial Fibrillation ablation procedures.

Detailed description

This study is part of a multiphase study. Phase 1 involves 10 patients at a single centre. Phase 2 will be done a multi centre study.

Interventions

DEVICEForesight ICE System

The Foresight ICE System is composed of a sterile, single-use catheter intended to operate with a Foresight ICE PIM and Hummingbird Console.

Sponsors

Conavi
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient is at least 18 years old. * Patient is undergoing an atrial fibrillation ablation procedure. * Patient has a transesophageal echocardiogram (TEE) within the 48 hours prior to ablation procedure to rule out left atrial thrombus. * Patient provides informed, written consent for participation in the study.

Exclusion criteria

* Patients in whom placement of an ICE catheter in the right atrium for adequate atrial visualization is not technically feasible (as evaluated and determined by the physician performing the procedure). * Patients in whom transseptal puncture is relatively contraindicated. * Patients in whom left atrial clot or dense spontaneous contrast is identified on TEE, which would increase thromboembolic risk. * Women of child bearing potential, in whom pregnancy cannot be excluded. * Patients unable to grant informed, written consent for participation in the study.

Design outcomes

Primary

MeasureTime frame
Successful transseptal puncture during atrial fibrillation ablation procedure under the guidance of study deviceDuring ablation procedure (2-4 h)

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026